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NMDA type glutamate receptors (NMDARs) are best known for
their role in synaptogenesis and synaptic plasticity. Much less is
known about their developmental role before neurons form syn-
apses. We report here that VEGF, which promotes migration of
granule cells (GCs) during postnatal cerebellar development,
enhances NMDAR-mediated currents and Ca2+ influx in immature
GCs before synapse formation. The VEGF receptor Flk1 forms
a complex with the NMDAR subunits NR1 and NR2B. In response
to VEGF, the number of Flk1/NR2B coclusters on the cell surface
increases. Stimulation of Flk1 by VEGF activates Src-family kinases,
which increases tyrosine phosphorylation of NR2B. Inhibition of
Src-family kinases abolishes the VEGF-dependent NR2B phosphor-
ylation and amplification of NMDAR-mediated currents and Ca2+
influx in GCs. These findings identify VEGF as a modulator of
NMDARs before synapse formation and highlight a link between
an activity-independent neurovascular guidance cue (VEGF) and an
activity-regulated neurotransmitter receptor (NMDAR).
angiogenesis | neurovascular link | neuronal migration | cerebellum
VEGF and its receptor Flk1 (VEGFR-2) regulate severalneurobiological processes in normal and pathological con-
ditions (1). They stimulate neurogenesis, long-term potentiation,
and learning, whereas low VEGF levels cause or aggravate
motoneuron degeneration, and VEGF delivery delays paralysis
in preclinical models (1). During cerebellar development, VEGF
chemoattracts granule cells (GCs) from the external GC layer
(EGL) toward the internal GC layer (IGL) (2). This chemotactic
activity of VEGF for GCs in vivo is mediated by direct activation
of Flk1 in GCs, independently of its angiogenic activity (2).
However, the mechanisms via which VEGF regulates GC mi-
gration in the cerebellum remain unknown.
NMDA type glutamate receptors (NMDARs) are ligand-gated
ion channels, permeable for Ca2+ (and other) ions that have
been implicated in synaptic transmission and plasticity (3, 4), and
may induce excitotoxicity upon excessive activation (5). In-
terestingly, before neurons establish synapses, activation of
NMDARs results in Ca2+ influx ([Ca2+]i), which promotes,
among other processes, proliferation and survival of neuroblasts
(6, 7), filopodia formation and growth cone turning (8, 9), and
migration of cortical and cerebellar neurons (10–13). In general,
NMDARs have been less extensively studied before synapse
formation than at developing or established synapses (14–16). It
remains to be established whether NMDARs can be regulated by
guidance cues during neuronal migration and, if so, the mecha-
nism via which this process occurs has not been explored.
Prompted by findings that VEGF (1) and NMDARs (3, 17, 18)
regulate neurogenesis, plasticity, and repair, we hypothesized that
Flk1 activation might regulate NMDAR function. Because both
NMDARs (NR1 and NR2B subunits) and Flk1 are expressed by
migrating GCs (2, 19, 20) and regulate GC migration (2, 11–13),
we explored a possible link between VEGF and NMDARs in
GCs before synaptogenesis, when there are no excitatory gluta-
matergic synaptic inputs on GCs (21). Our findings identify
VEGF as a modulator of NMDAR function in neurons before
synapses are formed. We identify a unique interaction between
receptors for a classic neurotransmitter and a prototypic angio-
genic factor, which regulate neuronal migration in the devel-
oping cerebellum.
Results
VEGF Enhances NMDAR-Mediated [Ca2+]i and Currents in GCs. To
explore whether VEGF affects GC migration in part by modu-
lating the NMDA response of migrating GCs, we examined by
fura-2 fluorescence imaging whether activation of Flk1 by VEGF
enhances [Ca2+]i via NMDARs in GCs. Isolated GCs from post-
natal day 5 (P5)mice, cultured for 1.0–1.5 d in vitro (DIV), express
markers for EGL-like postmitotic GCs (22) but have not formed
functional synapses yet (22, 23).BecauseVEGFcan stimulateCa2+
release from intracellular stores (24, 25) and [Ca2+]i through
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other channels than NMDARs (24, 26, 27), we selected a con-
centration ofVEGF that, by itself, failed to elevate [Ca2+]i inGCs.
GCswere stimulated with a pulse of NMDA, exposed to vehicle or
VEGF, and thereafter exposed again to NMDA. The increased
[Ca2+]i response to NMDA was comparable for the first and sec-
ond pulse (Fig. S1A). However, whenGCs were exposed to VEGF
before the second NMDA pulse, the [Ca2+]i response to the sec-
ond pulse was increased compared with the first (Fig. 1 A and B),
suggesting that VEGF enhanced NMDAR-mediated [Ca2+]i.
Control experiments showed that the NMDAR antagonist D-
2-amino-5-phosphono-valerate (D-APV), added during the sec-
ond NMDA pulse, abrogated the VEGF plus NMDA response
(Fig. 1C), demonstrating that the VEGF effect is mediated via
NMDARs. Incubation with an anti-Flk1 blocking antibody
(αFlk1) (28), but not a control IgG, for 15 min before and during
VEGF stimulation, blocked the VEGF-dependent increase in
[Ca2+]i (Fig. 1D and Fig. S1 B and C), revealing that binding of
VEGF to its receptor Flk1 is required. αFlk1 did not alter
NMDAR channel properties because it did not further reduce
the NMDA signal (Fig. 1D and Fig. S1C). Similar findings were
obtained when using the VEGF receptor tyrosine kinase in-
hibitor PTK787 (PTK) (Fig. S1D), showing that Flk1 signaling is
required for the VEGF effect.
To further dissect the molecular characteristics of this VEGF-
mediated effect on NMDAR, we reconstructed the cross-talk in
cellulo by cotransfectingHEK-293 cells withNR1 andNR2B, with
Flk1, or with the three together. When HEK-293 cells were
cotransfected with only NR1 and NR2B, VEGF failed to poten-
tiate the [Ca2+]i, indicating that VEGF did not directly affect
NMDAR (Fig. S2A). Conversely, VEGF failed to increase [Ca2+]i
in cells transfected only with Flk1, indicating that VEGF did not
induce a change in [Ca2+]i by itself but required the presence of
NMDARs (Fig. S2B).When all players were cotransfected,VEGF
amplified the NMDA-induced [Ca2+]i (Fig. S2C). Without
VEGF, the second pulse of NMDAdid not increase [Ca2+]i above
the level induced by the first pulse (Fig. S2D). Thus, VEGF
potentiates NMDAR-mediated [Ca2+]i in GCs before synapse
formation and in cotransfected HEK-293 cells via Flk1 signaling.
We also confirmed that the VEGF-dependent enhancement of
NMDAR activity was operational in GCs in situ. In the cere-
bellum, Flk1 is present in migrating GCs, whereas Flt1/VEGFR-
1 is not detectable (2). We used whole-cell patch–clamp tech-
niques in acute cerebellar slices of P9–P10 mice to record
NMDA-evoked currents in GCs in the lower layer of the EGL,
before synapse formation (21). Because no synaptic events were
recorded in GCs from the lower EGL (Fig. S3 A and B), con-
sistent with the absence of synaptic input in migrating GCs (21),
we superfused NMDA and its receptor antagonist D-APV and
applied VEGF topically to minimize possible indirect effects.
Application of VEGF alone induced only a small inward current
(Fig. S3 C–E). Consistent with previous reports (20, 29), NMDA
evoked an inward current in GCs in the lower EGL (Fig. 1 E–H).
Notably, VEGF enhanced the NMDA-induced current already
within 10–15 min by more than twofold (Fig. 1 E–H). This
VEGF-induced potentiation was observed when NMDA was
used at 50 μM or lower concentrations (Fig. S4A) and was
blocked by D-APV (Fig. 1 G and H), indicating that the VEGF
response in GCs is mediated through NMDARs.
To evaluate whether the effect of VEGF on NMDAR is me-
diated by Flk1 signaling, we silenced Flk1 in GCs by ex vivo
electroporation (2). We generated a shRNA construct to silence
Flk1 (Flk1KD) and used a scramble as control (Flk1Ctl). Valida-
tion experiments showed detectable Flk1 protein levels in HEK-
293 cells transfected with a Flk1-expression plasmid and Flk1Ctl
(Fig. S4B). In contrast, cotransfection with Flk1-expression plas-
mid and Flk1KD abolished Flk1 expression (Fig. S4B), indicating
silencing by Flk1KD. These constructs were coelectroporated with
an EGFP expression vector in cerebella ex vivo, and cerebellar
slices were cultured as described (2). After 3 d in culture, whole-
cell patch–clamp recordings of GFP+ GCs in the lower EGL
showed that Flk1 silencing abrogated the VEGF-induced poten-
tiation of NMDAR-mediated currents (Fig. S4C). Thus, the
VEGF-evoked increase in [Ca2+]i and currents in GCs require
Flk1 and are mediated via NMDARs before synapse formation.
Flk1 Interacts with NMDARs. Prompted by the link between VEGF
andNMDAR,weassessedwhetherFlk1 associateswithNMDARs
in GCs. During cerebellar development, Flk1 and NR2B are
expressed in migrating GCs and are needed for GC migration (2,
12, 13). Both molecules were found to be coexpressed by GCs
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Fig. 1. VEGF enhances NMDA-stimulated [Ca2+]i and NMDAR-mediated cur-
rents in GCs. (A) Representative single GC tracing of intracellular [Ca2+]i levels
obtained by Ca2+ imaging. GCs were stimulated with NMDA, exposed to
control buffer or VEGF, and stimulated a second time with NMDA. VEGF am-
plified the second NMDA response. (B) Quantification of the VEGF-response.
(Left) The difference betweenmaximum [Ca2+]i level and baseline [Ca
2+]i level
(ΔCa2+) was increased with VEGF (n = 26, ***P < 0.001). (Center) The maximal
derivativeof the rise in [Ca2+]i levels (d[Ca
2+]i/dt), the slope,was enhancedwith
VEGF (n = 26, ***P < 0.001). (Right) The area under the curve (AUC) was also
increased with VEGF (n = 26, ***P < 0.001). (C) Single GC tracing of [Ca2+]i
showing blockage of [Ca2+]i by D-APV. (D) Measurements of ΔCa2+ revealing
inhibition of VEGF-dependent increase in [Ca2+]i by αFlk1 but not by control
IgG (n = 44, ***P < 0.001 for IgG; n = 50, P = not significant for αFlk1). (E)
Representative whole-cell patch–clamp recording of a GC in the lower EGL,
revealing enhancement of the NMDA-induced current by VEGF. (F) Current–
voltage relationship of the GC responses shown in E revealing increased in-
ward currents in response to NMDA plus VEGF compared with NMDA alone
(n = 26, ***P < 0.001). (G) Representative whole-cell patch-clamp recording
showing that D-APVblocked theVEGF-enhancement of theNMDAR-mediated
current. (H) NMDAR conductancewas higher afterVEGFplusNMDA thanafter
NMDA alone; this conductance was blocked by D-APV (n = 7; *P < 0.05 in
VEGF+NMDAvs.NMDA;*P<0.05 inVEGF+NMDAvs.VEGF+NMDA+D-APV).
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when migrating along Bergmann glia fibers in vitro (Fig. 2A).
We therefore focused on NR2B. We immunoprecipitated Flk1
from GCs, or from cotransfected HEK-293 cells, and immuno-
blotted these precipitates with anti-NR1 or anti-NR2B antibodies.
NMDAR subunits coimmunoprecipitated with Flk1 in both cell
types, whereas a control antibody was ineffective (Fig. 2 B and C).
Similar results were obtained when anti-NR2B was used for im-
munoprecipitation and anti-Flk1 was used for immunoblotting
(data not shown), indicating that Flk1 and NR1/NR2B associate
with each other.
We next investigated whether Flk1 and NMDARs cluster to-
gether on the cell surface of GCs, before forming synapses. Be-
cause VEGF enhanced NMDAR-mediated [Ca2+]i and currents
in GCs within 10–15 min after application, we stimulated GCs
(1 DIV) for 10 min with VEGF and stained nonpermeabilized
GCs for Flk1 and NR2B. High-resolution imaging was used to
determine receptor clusters by using established methods (14)
(Fig. S5 A–H). In baseline, Flk1 was present on the cell surface
but only a few Flk1 clusters were formed, NR2B clusters were
readily detected, and only a few Flk1/NR2B coclusters were
present (Fig. 2D). Notably, VEGF increased the number of Flk1
clusters and Flk1/NR2B coclusters, without affecting the number
of NR2B clusters (Fig. 2D). Exposure of GC growth cones to
VEGF-soaked heparin beads also increased the surface expres-
sion of NR2B and Flk1 (Fig. S5 I and J). Thus, Flk1 interacts with
NR1 and NR2B, and VEGF increases the number of Flk1/NR2B
coclusters on the GC surface.
Flk1 Activation by VEGF Enhances NR2B Phosphorylation via Src-
Family Kinases (SFKs). Phosphorylation of NMDARs by SFKs
increases NMDAR-mediated currents and [Ca2+]i (30, 31). SFKs
phosphorylate tyrosine residues in the intracellular tail of NR2B,
leading to a greater number of active NMDARchannels at the cell
surface (32, 33). We thus examined whether the amplification of
the NMDAR-dependent [Ca2+]i by VEGF/Flk1 in GCs relied on
an increase in NR2B tyrosine phosphorylation by SFKs. VEGF
activated SFKs in GCs, as revealed by the increased SFK-Tyr416
phosphorylation (Fig. 3A). To explore whether VEGF also stim-
ulates phosphorylation of NR2B, GCs lysates were immunopre-
cipitated with an antibody for phosphorylated tyrosine (pTyr), and
precipitates were immunoblotted for NR2B. As shown in Fig. 3B,
VEGF increased NR2B tyrosine phosphorylation in GCs.
To facilitate further molecular mapping of this pathway, we
used cotransfected HEK-293 cells because this cellular model
exhibits the same VEGF-induced effect on NMDARs as GCs (as
described above). As expected, VEGF activated Flk1 signaling,
revealed by increased phosphorylation of Flk1-Tyr1173 (Fig. 3C).
VEGF also increased the phosphorylation of Flk1-Tyr949, acting
as a docking site for SFKs (34, 35) (Fig. 3C). Immunoblotting for
αSrc-pTyr416 showed that VEGF activated SFKs (Fig. 3D and
Fig. S6B). Finally, VEGF also increased tyrosine phosphoryla-
tion of NR2B (Fig. 3E). This phenomenon was also observed
when VEGF was used in combination with NMDA (Fig. S6A).
We next analyzed whether the increase in NR2B phosphoryla-
tion by VEGF relied on SFKs. We therefore coexpressed NR1,
NR2B, and Flk1 together with an active form of Src (SrcWT) or
a dominant-negative mutant form of Src (SrcDN) in which the ki-
nase domain was inactivated (K295R) and the regulatory domain
was mutated (Y527F); this dominant-negative SrcDN is well known
to block SFKs (36, 37). SrcDN abrogated the increase in NR2B ty-
rosine phosphorylation byVEGF (Fig. 3F and Fig. S6A andB).We
also used a NR2B mutant (NR2BTM) in which the tyrosine resi-
dues that become phosphorylated by SFKs are mutated to phe-
nylalanines and are no longer phosphorylated (15). Coexpression
of Flk1, NR1, and NR2BTM abolished VEGF-induced NR2B
phosphorylation (Fig. 3G). Thus, activation of Flk1 by VEGF
stimulated SFK-dependent tyrosine phosphorylation of NR2B.
VEGF Enhances NMDAR-Mediated [Ca2+]i and Currents via SFKs. To
link the VEGF-induced phosphorylation of NR2B to the in-
creased NMDAR-mediated [Ca2+]i by VEGF, we measured
the [Ca2+]i in HEK-293 cells cotransfected with Flk1, NR1,
and either NR2B or NR2BTM. Compared with controls, cells
expressing NR2BTM did not exhibit the VEGF-dependent am-
plification of the NMDA-induced [Ca2+]i (Fig. 3H). Further-
more, to demonstrate an involvement of SFKs, we blocked the
SFK activity in electrophysiological measurements directly in
the recorded GCs by administering the SFK inhibitor PP1 via the
patch pipette using previously described methods (38). SFK
blockade abolished the amplification of the NMDAR-mediated
currents by VEGF in GCs, whereas the inactive homolog PP3
was ineffective (Fig. 3I and Fig. S7 A and B). Calcium imaging
studies in GCs confirmed that PP1, but not PP3, abrogated the
potentiation by VEGF of the [Ca2+]i transients in response to
NMDA (Fig. 3J and Fig. S7 C and D). Thus, VEGF-dependent
activation of SFKs enhances NMDAR currents and [Ca2+]i via
tyrosine phosphorylation of NR2B.
VEGF Promotes GC Migration via NMDAR Activation. We recently
reported that VEGF attracts GCs during cerebellar development
(2). To explore the physiological relevance of the VEGF/
NMDAR link in this process, we used a modified Boyden
chamber assay (39) and counted GCs migrating to the lower side
of the filter. When VEGF was added to the lower compartment,
GC migration was enhanced, indicating that VEGF is chemo-
tactic for GCs (Fig. 4A and Fig. S8A). Addition of D-APV to the
upper chamber did not affect GC motility, suggesting that en-
dogenous glutamate, released by GCs (40), could not activate
NMDAR in these conditions (Fig. 4A). However, when added
together with VEGF, D-APV reduced the chemotactic GC re-
sponse to VEGF (Fig. 4A), implying that the effect of VEGF
relies on NMDAR activation. These data suggest a model
whereby VEGF sensitized NMDAR to the low levels of endog-
enous glutamate and thereby stimulated GC migration.
To further underscore the relevance of the VEGF/NMDAR
link for GC migration in a more in vivo-like microenvironment,
A
B
D
C
Fig. 2. Flk1 associates with NR1 and NR2B. (A) Confocal image of a GC
migrating along a glia fiber (GFAP+; gray/white), showing Flk1 (green) and
NR2B (red) expression at the plasma membrane; counterstaining is DAPI
(blue). (B and C) Lysates of GCs (B) or cotransfected HEK-293 cells (C) were
immunoprecipitated with an anti-Flk1 antibody (α-Flk1) or with a control IgG
and immunoblotted for NR1 (top lane), NR2B (middle lane), or Flk1 (bottom
lane). (D) Quantification of Flk1 or NR2B clusters and of Flk1/NR2B coclusters
at the GC surface, revealing that VEGF stimulation did not affect the number
of NR2B clusters (n = 54–46, P = not significant) but increased the number of
Flk1 clusters (n = 54–46, ***P < 0.001) and Flk1/NR2B coclusters (n = 54–46,
*P < 0.05 for coclusters per cell; **P = 0.005 for percentage of coclusters/
NR2B clusters). (Scale bar: A, 5 μm.)
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we used organotypic cerebellar slices (39). Migrating GCs were
traced by labeling proliferating GCs with a BrdU pulse in vivo at
P10, 3 h before we dissected the cerebella and cultured the slices.
Treatment with αFlk1 reduced GC migration, showing that en-
dogenous VEGF regulated GC migration (Fig. 4B), as reported
in our in vivo findings (2). Consistent with previous results (11),
treatment of slices with D-APV inhibited GC migration (Fig. 4B
and Fig. S8C), indicating that endogenous glutamate activates
NMDARs in these conditions. To explore whether endogenous
VEGF sensitized NMDARs to endogenous glutamate, we trea-
ted slices with αFlk1 and D-APV together. We reasoned that, if
VEGF would regulate GC migration independently of NMDAR,
blockage of Flk1 plus NMDAR should induce a greater effect
than single blockage of each molecule alone. If, however, VEGF
would regulate GC migration by enhancing NMDAR activity
through a Flk1/NMDAR modulation, then one would expect not
only that αFlk1 and D-APV should induce a comparable anti-
migratory effect (Fig. 4B) but also that combined blockage of
Flk1 and NMDAR should not induce a greater effect than single
blockage of either molecule alone. In support of the latter
mechanism, αFlk1 plus D-APV did indeed not reduce GC mi-
gration more than each compound alone (Fig. 4B). Similar
results were obtained when GC migration was analyzed in
organotypic slices from cerebella electroporated with shRNA
constructs for Flk1 (Flk1KD) and treated with D-APV (Fig. S8C).
Discussion
In this study, we identified VEGF as a modulator of NMDAR
function before synapse formation and documented a unique link
between a receptor for a classic neurotransmitter (NMDAR) and
a receptor for an angiogenic factor and a neuronal guidance cue
(Flk1), both of which are needed for proper GC migration in the
developing cerebellum. A combination of electrophysiological,
biochemical, Ca2+ imaging, and other cell-biological studies in
primary GCs and transfected HEK-293 cells revealed that Flk1
associates with NR1 and NR2B in a complex, that Flk1 and
NMDARs form increased numbers of coclusters in GCs upon
VEGF stimulation, and that VEGF increases NMDAR-mediated
currents and [Ca2+]i. The rapidity of the VEGF-mediated am-
plification of the NMDAR activity (within minutes) suggests that
this modulation relies on posttranslational mechanisms. Indeed,
VEGF stimulated NMDARs via SFK-dependent phosphoryla-
tion of tyrosine residues in the cytosolic domain of NR2B.
Overall, these results identify a molecular framework whereby
binding of VEGF to Flk1 activates SFKs, leading to NR2B
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DCFig. 3. VEGF-dependent SFK activationinduces NR2B tyrosine phosphorylation
and potentiation of NMDAR activity. (A)
Immunoblot of GC lysates using anti-
bodies against SFK-pTyr416 (αSrc-pTyr416)
or total Src (αSrc) showing increased ac-
tivation of SFKs after VEGF stimulation.
(B) GC lysates were immunoprecipitated
with an anti-pTyr antibody and immu-
noblotted for NR2B, showing increased
NR2B phosphorylation upon VEGF stim-
ulation. Bottom lane shows the NR2B
immunoblot of total cell lysates. (C)
Lysates of cotransfected HEK-293 cells
immunoblotted for Flk1-pTyr1173 or Flk1-
pTyr949 (top and middle lanes) or total
Flk1 (bottom lane), showing that VEGF
activated Flk1. (D) Lysates of cotrans-
fected HEK-293 cells were immuno-
blotted for pTyr416-SFK or total Src,
showing that VEGF activated SFKs. (E)
Lysates of cotransfected HEK-293 cells
were immunoprecipitated with an anti-
pTyr antibody and immunoblotted for
NR2B, showing that VEGF induced NR2B
phosphorylation (upper lane). Immuno-
blotting of cell lysates showed compa-
rable expression of NR2B (lower lane).
(F) Lysates of HEK-293 cells, cotrans-
fected with WT Src (SrcWT) or dominant-
negative Src (SrcDN) together with NR1,
NR2B, and Flk1, were immunoprecipi-
tated with an anti-pTyr antibody and
immunoblotted for NR2B, showing in-
creased NR2B phosphorylation in SrcWT
but not in SrcDN cells (top lane). Immu-
noblotting of cell lysates showed com-
parable expression of NR2B (middle lane)
and increased levels of Flk1-pTyr1173 in
response to VEGF (bottom lane). (G)
Lysates of HEK-293 cells cotransfected with
NR2BTM, NR1, and Flk1 were immuno-
precipitated with an anti-pTyr antibody
and immunoblotted for NR2B, showing that VEGF did not increase phosphorylation of NR2BTM (top lane). Immunoblotting of cell lysates showed comparable
expression of NR2BTM (middle lane) and increased levels of Flk1-pTyr1173 in response to VEGF (bottom lane). (H) The increase in NMDAR-stimulated [Ca2+]i
(ΔCa2+) was observed in HEK-293 cells cotransfected with Flk1, NR1, and NR2B (n = 21, ***P < 0.001) but not with Flk1, NR1, and NR2BTM (n = 44, P = not
significant). (I) The increase in NMDAR whole-cell patch-clamp conductance by VEGF was inhibited by PP1 (n = 7, P = not significant) but not by PP3 (n = 7,
**P < 0.01). (J) The increase of the NMDA-induced ΔCa2+ by VEGF was blocked by PP1 (n = 36, P = not significant) but not by PP3 (n = 50, ***P < 0.001).
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phosphorylation and enhancement of NMDAR-mediated cur-
rents and [Ca2+]i.
The molecular pathways via which VEGF promotes neuronal
migration and neurite outgrowth are largely unknown, in con-
trast to the wealth of information about the molecular signaling
mechanisms of VEGF/Flk1 in endothelial cells (34). In these
cells, binding of VEGF to Flk1 stimulates migration and vascular
permeability in part via activation of SFKs (41). Our studies in
GCs now show that VEGF also activates SFKs in these neurons
and that SFKs transmit intermediary signals from Flk1 to
NMDAR to enhance the conductance and [Ca2+]i of NMDAR
channels. SFKs regulate NMDARs in part by preventing in-
ternalization of activated surface-exposed NMDARs as well as
by regulating ion channel properties (32). In GCs in the absence
of synapses, we also observed that VEGF increased the forma-
tion of cell surface Flk1/NR2B coclusters.
During postnatal cerebellar development, migrating GCs
predominantly express the NR2B subunit (19), and, when
blocked, GC migration is impaired (12). Further evidence that
NMDARs regulate GC migration is provided by findings that
GC migration is inhibited by NMDAR blockade and accelerated
by enhanced NMDAR activity (11, 13). In a recent study, we
documented that VEGF controls GC migration as a chemotactic
guidance cue in the developing cerebellum in vivo (2). Using the
Boyden chamber assay in vitro and the organotypic cerebellar
slice model ex vivo, we now show that VEGF is chemotactic for
GCs in a NMDAR-dependent manner. Because elevated Ca2+
levels in response to NMDAR activation promote filopodia
formation, turning responses, and neuronal motility (8, 11, 42),
amplification of NMDARs activity by VEGF would enhance
neuronal migration. Because VEGF is present as a gradient in
the developing cerebellum (2), sensitization of NMDARs by
VEGF to glutamate may explain why migrating GCs become
progressively chemoattracted to the highest levels of VEGF in
the deeper layers of the cerebellar cortex. The finding that ac-
tivation of Flk1 and NMDAR together also stimulates chemo-
kinesis (Fig. S8B) may further explain how VEGF regulates GC
migration. Overall, this study provides unique molecular mech-
anistic insights in how VEGF regulates neuronal migration.
Previous studies documented that ephrin-b2 and neuregulin
enhance the activity of NMDARs through SFK-dependent phos-
phorylation of particular NR2 subunits (15, 43). In contrast to our
study, however, those reports documented regulation of synaptic
NMDAR at the postsynaptic site and reported how these mole-
cules amplified the activity ofNMDAR in synaptogenesis, synaptic
transmission, and plasticity. We show here that VEGF modulates
the NMDAR activity during migration of immature GCs before
they form synapses. Intriguingly, however, the VEGF/NMDAR
link may not be restricted alone to NMDARs before synapse
formation and be even of broader (patho)physiological relevance
because hippocampal and motor neurons, known to express syn-
aptic NMDARs (NMDARs), also express Flk1 (44, 45).
Overall, the role for VEGF as a modulator of NMDAR activity
provides further evidence for the importance of the neurovascular
link. Given the expression of VEGF and Flk1 in many cell types in
the central nervous system (1, 46) as well as the general implication
of NMDARs in numerous neurobiological processes in health and
disease, these findings also raise intriguing questions about the
possible role of this identified VEGF/NMDAR link in non-
developmental processes, including learning, memory, synaptic
plasticity, and neurodegeneration. It will be also necessary to fur-
ther dissect the molecular details of how VEGF precisely influ-
ences the activity ofNMDARs in providing neuroprotection versus
excitotoxicity (47). Furthermore, defects in stimulating NMDAR
phosphorylation by neuregulin has been implicated in the patho-
genesis of schizophrenia (46, 48). More speculatively, it will be
therefore interesting to examine whether defective stimulation of
NMDAR phosphorylation by insufficient VEGF might also in-
crease the susceptibility of neurons to dysfunction or degeneration.
As for now, our findings of how an activity-independent signal
(VEGF) regulates a receptor for a classic neurotransmitter provide
a unique insight into the molecular basis of brain wiring.
Materials and Methods
GC Purification and Chemotaxis Assay.GCs were purified as described in ref. 49.
Immunohistochemistry. Purified GCs were fixed in nonpermeable conditions
and stained with antibodies recognizing extracellular epitopes of the cor-
responding proteins. Cerebellar slices were fixed for 2 h in 4% PFA at room
temperature and subsequently processed for BrdU immunostaining.
Analysis of Flk1 and NR2B Coclusters. Analysis of Flk1 and NR2B coclusters was
performed by using the image analysis software package Imaris (version
6.3.1) (Fig. S5). Clusters were detected in the maximum projection of 3D
confocal z-stack images.
Electrophysiological Recordings. Whole-cell patch–clamp recordings were
performed on acute parasagittal cerebellar slices (200–300 μm thick) (2, 50)
from P8 C57BL6 mice. GCs were characterized electrophysiologically by their
absence of action potentials and synaptic events and by their high input
resistance and small cell capacitance (29). NMDA (50 μM; Tocris) was added
to the perfusion solution, and VEGF (150 ng/mL; R&D Systems) was topically
applied by pressure (Picospritzer II). NMDAR-mediated responses were
blocked with D-APV (50 μM; Tocris).
Ex Vivo Cerebellar Electroporation. Cerebella dissected from P8 or P10 mice
were electroporated as previously described (2). See SI Materials and
Methods for details of the used shRNAi constructs.
Transfection of HEK-293 Cells. The following plasmids were used for trans-
fection: Flk1, NR1, NR2B-GFP (termed NR2B), NR2BTM, SrcWT, SrcDN, shFlk1KD,
and shFlk1Ctl. For the phosphorylation experiments, cells were starved 1 d
after transfection in 0.1% serum containing medium for 16–20 h.
A
B
Fig. 4. VEGF-induced potentiation of NMDAR activity promotes GC mi-
gration. (A) Quantification of GC migration in Boyden chamber assay,
showing that supplementation of D-APV (10 μM) to the upper chamber (blue
bar) does not affect GC motility compared with the control condition (white
bar). When VEGF (50 ng/mL) is added to the lower chamber (red bar), GC
migration is increased. This increase is inhibited by adding D-APV (10 μM) in
the upper chamber (black bar, *P < 0.05). (B) Analysis of GC migration in
organotypic cerebellar slices [expressed as percentage of BrdU+ GCs in the
IGL versus total number of BrdU+ GCs in EGL, molecular layer (ML), and IGL],
showing inhibition of GC migration upon αFlk1 treatment (red bar) and
upon D-APV treatment (blue bar). The combination of αFlk1 and D-APV does
not reduce GC migration further (black bar; ***P < 0.001).
13786 | www.pnas.org/cgi/doi/10.1073/pnas.1100341108 Meissirel et al.
Calcium Imaging. Cell cultures ofprimaryGCs (1–1.5DIV)or transfectedHEK-293
cellswere loadedwith5 μMfura-2-acetoxymethyl esterplus0.1%Pluronic F-127
(Molecular Probes) and incubated for 60 min in Hepes-buffered saline solution
(HBSS). NMDApulses andwasheswere performedwith a perfusion system, and
the rest of the incubations and treatments were performed without perfusion.
Immunoprecipitation and Immunoblotting. GCs or transfected HEK-293 cells
were stimulated with VEGF (50 ng/mL) for 15 or 5 min, respectively, and lysed
afterward. For immunoprecipitation, 400 μg of protein extract was incu-
bated overnight at 4 °C with the antibody of interest.
Culture and Treatment of Organotypic Cerebellar Slices. Cerebellar slices were
cultured for 4 d as described previously (51). Slices were treated either with
αFlk1 (30 μg/mL; ATCC), D-APV (25 μM), or a combination of αFlk1 plus D-APV
by adding them to the culture medium.
Statistics. Unless specifically stated, data are expressed as mean ± SEM.
Statistical analysis were performed by applying a paired Student’s t test.
Please see SI Materials and Methods for detailed experimental
procedures.
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